Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 1
2012 4
2013 17
2014 13
2015 31
2016 29
2017 24
2018 35
2019 23
2020 12
2021 5
2022 3
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

191 results

Results by year

Filters applied: . Clear all
Page 1
Non-small-cell lung cancer.
Gridelli C, Rossi A, Carbone DP, Guarize J, Karachaliou N, Mok T, Petrella F, Spaggiari L, Rosell R. Gridelli C, et al. Among authors: karachaliou n. Nat Rev Dis Primers. 2015 May 21;1:15009. doi: 10.1038/nrdp.2015.9. Nat Rev Dis Primers. 2015. PMID: 27188576 Review.
INSIGHT 2: a phase II study of tepotinib plus osimertinib in MET-amplified NSCLC and first-line osimertinib resistance.
F Smit E, Dooms C, Raskin J, Nadal E, Tho LM, Le X, Mazieres J, S Hin H, Morise M, W Zhu V, Tan D, H Holmberg K, Ellers-Lenz B, Adrian S, Brutlach S, Schumacher KM, Karachaliou N, Wu YL. F Smit E, et al. Among authors: karachaliou n. Future Oncol. 2022 Mar;18(9):1039-1054. doi: 10.2217/fon-2021-1406. Epub 2021 Dec 17. Future Oncol. 2022. PMID: 34918545 Free article.
Overcoming MET-mediated resistance in oncogene-driven NSCLC.
Reischmann N, Schmelas C, Molina-Vila MÁ, Jordana-Ariza N, Kuntze D, García-Roman S, Simard MA, Musch D, Esdar C, Albers J, Karachaliou N. Reischmann N, et al. Among authors: karachaliou n. iScience. 2023 May 29;26(7):107006. doi: 10.1016/j.isci.2023.107006. eCollection 2023 Jul 21. iScience. 2023. PMID: 37534190 Free PMC article.
Mechanisms of resistance to osimertinib.
Lazzari C, Gregorc V, Karachaliou N, Rosell R, Santarpia M. Lazzari C, et al. Among authors: karachaliou n. J Thorac Dis. 2020 May;12(5):2851-2858. doi: 10.21037/jtd.2019.08.30. J Thorac Dis. 2020. PMID: 32642198 Free PMC article. Review.
Clinical assessment of immune-related adverse events.
Sosa A, Lopez Cadena E, Simon Olive C, Karachaliou N, Rosell R. Sosa A, et al. Among authors: karachaliou n. Ther Adv Med Oncol. 2018 Mar 30;10:1758835918764628. doi: 10.1177/1758835918764628. eCollection 2018. Ther Adv Med Oncol. 2018. PMID: 29623110 Free PMC article. Review.
HER3 as a Therapeutic Target in Cancer.
Karachaliou N, Lazzari C, Verlicchi A, Sosa AE, Rosell R. Karachaliou N, et al. BioDrugs. 2017 Feb;31(1):63-73. doi: 10.1007/s40259-016-0205-2. BioDrugs. 2017. PMID: 28000159 Review.
Other targeted drugs in melanoma.
González-Cao M, Rodón J, Karachaliou N, Sánchez J, Santarpia M, Viteri S, Pilotto S, Teixidó C, Riso A, Rosell R. González-Cao M, et al. Among authors: karachaliou n. Ann Transl Med. 2015 Oct;3(18):266. doi: 10.3978/j.issn.2305-5839.2015.08.12. Ann Transl Med. 2015. PMID: 26605312 Free PMC article. Review.
Cancer immunotherapy of patients with HIV infection.
Gonzalez-Cao M, Martinez-Picado J, Karachaliou N, Rosell R, Meyerhans A. Gonzalez-Cao M, et al. Among authors: karachaliou n. Clin Transl Oncol. 2019 Jun;21(6):713-720. doi: 10.1007/s12094-018-1981-6. Epub 2018 Nov 17. Clin Transl Oncol. 2019. PMID: 30446984 Review.
Liquid biopsy for lung cancer early detection.
Santarpia M, Liguori A, D'Aveni A, Karachaliou N, Gonzalez-Cao M, Daffinà MG, Lazzari C, Altavilla G, Rosell R. Santarpia M, et al. Among authors: karachaliou n. J Thorac Dis. 2018 Apr;10(Suppl 7):S882-S897. doi: 10.21037/jtd.2018.03.81. J Thorac Dis. 2018. PMID: 29780635 Free PMC article. Review.
191 results